{"id":"W4386008142","doi":"10.1093/crocol/otad034","title":"Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Dosing; Internal medicine; Post-hoc analysis; Crohn's disease; Gastroenterology; Clinical trial; Maintenance therapy; Disease; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2523202,0.002280558,0.002253317,0.002779244,0.001319822,0.003143218,0.002573342,0.002543565,0.008634862],"category_scores_gemma":[0.3956338,0.000901741,0.007751791,0.002447904,0.002897296,0.002967539,0.00294632,0.002977241,0.0008174711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001492387,"about_ca_system_score_gemma":0.003052573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006829427,"about_ca_topic_score_gemma":0.001167209,"domain_scores_codex":[0.6431903,0.3200097,0.009611519,0.01050842,0.01433773,0.002342317],"domain_scores_gemma":[0.3706778,0.5543336,0.0285073,0.0274991,0.01729429,0.001687766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1116886,0.007796615,0.3163783,0.01312554,0.07080063,0.00428931,0.007746026,0.04209175,0.02157189,0.02399494,0.07360505,0.3069113],"study_design_scores_gemma":[0.02246686,0.1628515,0.2578374,0.003098188,0.03941764,0.002858255,0.007754009,0.1694908,0.03381269,0.03006215,0.2694905,0.0008601129],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5414314,0.005154592,0.3398735,0.006365963,0.004697791,0.06934209,0.01110951,0.001484284,0.0205408],"genre_scores_gemma":[0.7591025,0.0005066767,0.1734937,0.003515392,0.0006133351,0.05626613,0.003232702,0.000356756,0.002912764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2523202,"threshold_uncertainty_score":0.9220223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07314988302568722,"score_gpt":0.3828411585899901,"score_spread":0.3096912755643029,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}